CELLFORGE
LIVE

Serial Number

99734085

Owner

iOrganBio, Inc.

Attorney

Jeffrey P. Dunning

Filing Date

Mar 30, 2026

Add to watchlist:

No watchlists yet
View on USPTO

CELLFORGE Trademark

Serial Number: 99734085

CELLFORGE is a trademark filed by iOrganBio, Inc. on March 30, 2026. The trademark is classified under Class 1 (Chemicals), Class 9 (Computers & Electronics), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

iOrganBio, Inc.

137 E. Franklin Street
Chapel Hil, NC 27514

Entity Type: 03

Trademark Details

Filing Date

March 30, 2026

Registration Date

Not Registered

Goods & Services

Downloadable artificial intelligence powered software for cell therapy manufacturing, human tissue design, analyzing cellular state data, generating digital cell atlases, discovering and optimizing cell culture protocols, predicting cell differentiation outcomes, optimizing biomanufacturing workflows, collecting high-resolution cell telemetry data, and generating digital cell state references; multi-purpose cell culture device for processing organoids, stem cells, and primary cells for scientific and research use; computer hardware and recorded software systems for use in drug discovery, drug development, isolation and cultivation of human tissues and cells, cell therapy manufacturing and human tissue design

Custom manufacturing of cells, organoids and tissue models for use in scientific and medical research

Platform as a service (PAAS) featuring software for cell therapy manufacturing, human tissue design, analyzing cellular state data, generating digital cell atlases, discovering and optimizing cell culture protocols, predicting cell differentiation outcomes, optimizing biomanufacturing workflows, collecting high-resolution cell telemetry data, and generating digital cell state references; Software as a service (SaaS) featuring machine learning and reinforcement learning frameworks for closed-loop control of biomanufacturing systems; cloud-based software services for integrating laboratory instruments and automating cell therapy production workflows; scientific research in the fields of drug discovery, drug development, isolation and cultivation of human tissues and cells, cell therapy manufacturing and human tissue design; tissue characterization, namely, analysis of biological tissue properties using imaging processes; software orchestration services in the field of cell therapy manufacturing technology; scientific laboratory services relating to the isolation and cultivation of human tissues and cells; engineering services in the field of human tissue design and tissue engineering

Biological tissue, namely, cells, organoids and tissue models for use in scientific and medical research

Filing History

APPLICATION FILING RECEIPT MAILED
Mar 30, 2026 MAFR
NEW APPLICATION ENTERED
Mar 30, 2026 NWAP